Skip to main content

Xyzal News

FDA Medwatch Alert: Drug Safety Communication - FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines Cetirizine or Levocetirizine

May 23, 2025 -- The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare but severe itching. These m...

Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use

BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...

FDA Approves Xyzal For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria

ATLANTA and BRIDGEWATER, N.J., Aug. 24 /PRNewswire/ – UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved Xyzal (levocetirizine dihydrochloride)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Urticaria, Hives, Hay Fever, Allergic Rhinitis, Allergies

Xyzal patient information at Drugs.com